155 related articles for article (PubMed ID: 35249477)
1. An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Zhang F; Cai J; Hu K; Liu W; Lu S; Tang B; Li M; Wu W; Ren Z; Yin X
Comb Chem High Throughput Screen; 2022; 25(13):2203-2216. PubMed ID: 35249477
[TBL] [Abstract][Full Text] [Related]
2. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
[TBL] [Abstract][Full Text] [Related]
3. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
[TBL] [Abstract][Full Text] [Related]
4. Characterization and clinical verification of immune-related genes in hepatocellular carcinoma to aid prognosis evaluation and immunotherapy.
Qu J; Sun F; Hou Y; Qi H; Sun X; Xing L
BMC Cancer; 2023 Jun; 23(1):549. PubMed ID: 37322434
[TBL] [Abstract][Full Text] [Related]
5. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
6. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.
Wang Z; Song J; Azami NLB; Sun M
Front Immunol; 2022; 13():802665. PubMed ID: 35572595
[TBL] [Abstract][Full Text] [Related]
8. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progression.
Zhang B; Tang B; Lv J; Gao J; Qin L
Clin Immunol; 2022 Aug; 241():109073. PubMed ID: 35817291
[TBL] [Abstract][Full Text] [Related]
9. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
Front Immunol; 2022; 13():944286. PubMed ID: 36591255
[TBL] [Abstract][Full Text] [Related]
10. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
11. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
12. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification.
Yue Y; Tao J; An D; Shi L
J Gene Med; 2024 Jan; 26(1):e3611. PubMed ID: 37847055
[TBL] [Abstract][Full Text] [Related]
13. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
14. Identification of immune-related hub genes and construction of an immune-related gene prognostic index for low-grade glioma.
Zhou J; Guo H; Liu L; Jin Z; Zhang W; Tang T
J Cell Mol Med; 2023 Dec; 27(23):3851-3863. PubMed ID: 37775993
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma.
Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z
BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445
[TBL] [Abstract][Full Text] [Related]
16. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.
Wang Y; Yang Y; Zhao Z; Sun H; Luo D; Huttad L; Zhang B; Han B
BMC Cancer; 2022 Apr; 22(1):379. PubMed ID: 35397536
[TBL] [Abstract][Full Text] [Related]
17. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
19. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
20. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.
Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]